Raz I

References (2)

Title : An update on DPP-4 inhibitors in the management of type 2 diabetes - Cahn_2016_Expert.Opin.Emerg.Drugs_21_409
Author(s) : Cahn A , Cernea S , Raz I
Ref : Expert Opin Emerg Drugs , 21 :409 , 2016
Abstract : Cahn_2016_Expert.Opin.Emerg.Drugs_21_409
ESTHER : Cahn_2016_Expert.Opin.Emerg.Drugs_21_409
PubMedSearch : Cahn_2016_Expert.Opin.Emerg.Drugs_21_409
PubMedID: 27809608

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus - Raz_2006_Diabetologia_49_2564
Author(s) : Raz I , Hanefeld M , Xu L , Caria C , Williams-Herman D , Khatami H
Ref : Diabetologia , 49 :2564 , 2006
Abstract : Raz_2006_Diabetologia_49_2564
ESTHER : Raz_2006_Diabetologia_49_2564
PubMedSearch : Raz_2006_Diabetologia_49_2564
PubMedID: 17001471